RE: The HER2 assay being developed with Bioview can't be far off now6 Nov 2023 07:27
Agree EC however with the SP on its knees, sentiment poor why would the company simple update their website and tweet on the release of a CTC Biomarker on their Portrait Assay.
Makes little sense the investor reach is minimal.